Download original image
Fig. 4.

KCC2 antagonist maintains potassium homeostasis in mouse MIR137 cKO neurons. (A) Representative traces of action potentials in response to step current injections in primary neurons at DIV-14. Membrane potential was maintained at approximately –65 mV. Step currents were injected from -50 pA to +300 pA in 50 pA increments (bottom panel). WT, n=21; cKO, n=32; cKO+VU0240551, n=26. (B) Representative traces of whole-cell currents in voltage-clamp mode. Primary neurons were held at -70 mV. Step depolarization from -80 mV to +60 mV at 10-mV intervals was delivered (bottom panel). Insets showing respective traces on an expanded scale. WT, n=23; cKO, n=28; cKO+VU0240551, n=33. (C) The relationship between voltage and K+ current. (D) The peak amplitude of K+ current was reduced to normal in MIR137 cKO neurons that were treated with VU0240551, a specific antagonist for KCC2. (E~G) Statistics of intrinsic membrane properties in MIR137 WT and cKO hippocampal neurons treated with or without VU0240551. RMP, resting membrane potential (E); Rin, membrane input resistance (F); Cm, capacitance (G). *p<0.05, **p<0.01.

Exp Neurobiol 2020;29:138~149
© Exp Neurobiol